Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Pompili, Maurizio
Serafini, Gianluca
Innamorati, Marco
Ambrosi, Elisa
Telesforo, Ludovica
Venturini, Paola
Giordano, Gloria
Battuello, Michele
Lester, David
and
Girardi, Paolo
2011.
Unmet treatment needs in schizophrenia patients: is asenapine a potential therapeutic option?.
Expert Review of Neurotherapeutics,
Vol. 11,
Issue. 7,
p.
989.
De Hert, M.
Vancampfort, D.
Correll, C. U.
Mercken, V.
Peuskens, J.
Sweers, K.
van Winkel, R.
and
Mitchell, A. J.
2011.
Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation.
British Journal of Psychiatry,
Vol. 199,
Issue. 2,
p.
99.
Bernardo, Miquel
Vieta, Eduard
Saiz Ruiz, Jerónimo
Rico-Villademoros, Fernando
Álamo, Cecilio
and
Bobes, Julio
2011.
Recomendaciones para el cambio de antipsicóticos. Posicionamiento de la Sociedad Española de Psiquiatría y Sociedad Española de Psiquiatría Biológica.
Revista de Psiquiatría y Salud Mental,
Vol. 4,
Issue. 3,
p.
150.
Bernardo, Miquel
Vieta, Eduard
Saiz Ruiz, Jerónimo
Rico-Villademoros, Fernando
Álamo, Cecilio
and
Bobes, Julio
2011.
Recommendations for switching antipsychotics. A position statement of the Spanish Society of Psychiatry and the Spanish Society of Biological Psychiatry.
Revista de Psiquiatría y Salud Mental (English Edition),
Vol. 4,
Issue. 3,
p.
150.
Maayan, Lawrence
and
Correll, Christoph U.
2011.
Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents.
Journal of Child and Adolescent Psychopharmacology,
Vol. 21,
Issue. 6,
p.
517.
de Hoogd, Sjoerd
Overbeek, Wieske A.
Heerdink, Eibert R.
Correll, Christoph U.
de Graeff, Elisabeth R.
and
Staal, Wouter G.
2012.
Differences in Body Mass Index z-Scores and Weight Status in a Dutch Pediatric Psychiatric Population With and Without Use of Second-Generation Antipsychotics.
Journal of Child and Adolescent Psychopharmacology,
Vol. 22,
Issue. 2,
p.
166.
Goldbeck, Lutz
Plener, Paul L.
Resch, Franz
and
Fegert, Jörg M.
2012.
Psychiatrie und Psychotherapie des Kindes- und Jugendalters.
p.
177.
Moteshafi, Hoda
and
Stip, Emmanuel
2012.
Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.
Expert Opinion on Drug Safety,
Vol. 11,
Issue. 5,
p.
713.
Kölch, Michael G.
Plener, Paul L.
and
Fegert, Jörg M.
2012.
Handbuch der Psychopharmakotherapie.
p.
1185.
Harrison, Joyce Nolan
Cluxton-Keller, Fallon
and
Gross, Deborah
2012.
Antipsychotic Medication Prescribing Trends in Children and Adolescents.
Journal of Pediatric Health Care,
Vol. 26,
Issue. 2,
p.
139.
Rubin, David
Matone, Meredith
Huang, Yuan-Shung
dosReis, Susan
Feudtner, Chris
and
Localio, Russell
2012.
Interstate variation in trends of psychotropic medication use among Medicaid-enrolled children in foster care.
Children and Youth Services Review,
Vol. 34,
Issue. 8,
p.
1492.
De Hert, Marc
Detraux, Johan
van Winkel, Ruud
Yu, Weiping
and
Correll, Christoph U.
2012.
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
Nature Reviews Endocrinology,
Vol. 8,
Issue. 2,
p.
114.
Matone, Meredith
Localio, Russell
Huang, Yuan‐Shung
dosReis, Susan
Feudtner, Chris
and
Rubin, David
2012.
The Relationship between Mental Health Diagnosis and Treatment with Second‐Generation Antipsychotics over Time: A National Study of U.S. Medicaid‐Enrolled Children.
Health Services Research,
Vol. 47,
Issue. 5,
p.
1836.
Garcia, Georgina
Logan, Grace E.
and
Gonzalez-Heydrich, Joseph
2012.
Management of Psychotropic Medication Side Effects in Children and Adolescents.
Child and Adolescent Psychiatric Clinics of North America,
Vol. 21,
Issue. 4,
p.
713.
Hasnain, Mehrul
Vieweg, W. Victor R.
and
Hollett, Bruce
2012.
Weight Gain and Glucose Dysregulation with Second-Generation Antipsychotics and Antidepressants: A Review for Primary Care Physicians.
Postgraduate Medicine,
Vol. 124,
Issue. 4,
p.
154.
Morrato, Elaine H
2012.
An update on lipid profile screening in second-generation antipsychotic users in the USA.
Clinical Lipidology,
Vol. 7,
Issue. 5,
p.
509.
De Hert, Marc
Yu, Weiping
Detraux, Johan
Sweers, Kim
van Winkel, Ruud
and
Correll, Christoph U.
2012.
Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder.
CNS Drugs,
Vol. 26,
Issue. 9,
p.
733.
Abrahamian, Heidemarie
Kautzky-Willer, Alexandra
Rießland-Seifert, Angelika
Fasching, Peter
Ebenbichler, Christoph
Hofmann, Peter
and
Toplak, Hermann
2012.
Positionspapier: Psychische Erkrankungen und Diabetes mellitus.
Wiener klinische Wochenschrift,
Vol. 124,
Issue. S2,
p.
107.
Burton, Helen
and
Robb, Adelaide S.
2012.
Anorexia Nervosa and Antipsychotics: How to Apply Research Findings to the Adolescent Population.
Child and Adolescent Psychopharmacology News,
Vol. 17,
Issue. 6,
p.
1.
Sturmey, Peter
2012.
Treatment of Psychopathology in People with Intellectual and other Disabilities.
The Canadian Journal of Psychiatry,
Vol. 57,
Issue. 10,
p.
593.
Comments
No Comments have been published for this article.